An equivalent 10 mg/dl decrease in plasma ApoB concentration associated with LDLR score-related variants corresponds to a 0.4 mmol/L (14.1 mg/dl) reduction in LDL-C concentration, no alteration in TG, and a similarly decreased risk of CHD [OR 0.773 (95% CI, 0.747–0.801)]. This evidence concerns the gene APOB and coronary artery disorder.